Crossref

1. Metformin addition to androgen deprivation therapy effect on cancer prostate patients with type 2 diabetes

- Engy M. Aboelnaga

- Mohamed M. Aboelnaga

- Hend MHR. Elkalla

2. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells

- Yanju Wu

- Qianqian Zheng

- Yan Li

- Guang Wang

- Shuting Gao

- Xiaodong Zhang

- Xu Yan

- Xinwen Zhang

- Jisheng Xie

- Yuanyuan Wang

- Xun Sun

- Xin Meng

- Bo Yin

- Biao Wang

3. The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis

- Jons W. van Hattum

- Ben Max de Ruiter

- Jorg R. Oddens

- Theo M. de Reijke

- Johanna W. Wilmink

- Remco J. Molenaar

4. Expression of miR‑490‑5p, miR‑148a‑3p and miR‑608 in bladder cancer and their effects on the biological characteristics of bladder cancer cells

- Min Xiang

- Wuxiong Yuan

- Weiwei Zhang

- Jie Huang

5. A study of oral metformin for the intravesical treatment of non‐muscle‐invasive bladder cancer

- Jons W. van Hattum

- Marinka J. Remmelink

- Sieb T. Nuijens

- Ben Max de Ruiter

- Gerrit K.J. Hooijer

- Jorg R. Oddens

- C. Dilara Savci‐Heijink

- Ron Mathot

- J. Alfred Witjes

- Michael .N. Pollak

- Theo M. de Reijke

- Remco J. Molenaar

- Hanneke W. Wilmink